Adial Pharmaceuticals (NASDAQ:ADIL) just reported results for the fourth quarter of 2023.
- Adial Pharmaceuticals reported earnings per share of -37 cents. This was above the analyst estimate for EPS of -47 cents.
- The company did not report any revenue for the quarter.